Anthony King

I am a freelance science journalist based in Dublin, Ireland. I cover a variety of topics in chemical and biological sciences, as well as science policy, health and innovation.

My articles have appeared in Nature, Science, Cell, Chemistry World, New Scientist, the Irish Times, New York Times, EMBO Reports, Chemistry & Industry and more.

I enjoy writing on a wide breadth of subjects, from antibiotics to petrochemicals, bumblebees to asteroid composition, palaeontology to brain development. Previously I worked for a publishing company as a science editor.

My primary degree in science is from Trinity College Dublin and I hold a Master’s degree in science communications from Dublin City University.

Follow @https://twitter.com/AntonyJKing

Research
Moths draped in stealth acoustic cloak evade bat sonar
2020-11-26T09:30:00
Two species have wing scales covered in a complex metamaterial
Business
Oxford–AstraZeneca vaccine joins others with promising interim data
2020-11-24T13:09:00
Cheap and fridge-stable candidate at least 60% and up to 90% effective at preventing disease
Business
Regulatory panel unconvinced by Alzheimer’s antibody evidence
2020-11-20T09:29:00
US FDA advisors vote against approving Biogen’s aducanumab on the basis of incomplete data analysis
Business
Moderna and Pfizer’s Covid-19 vaccines add more encouraging data
2020-11-18T14:27:00
Pfizer–BioNTech reach safety threshold for emergency authorisation, while Moderna’s data peek suggests 95% efficacy
Business
Early indications suggest Pfizer–BioNTech’s Covid-19 vaccine is effective
2020-11-10T15:29:00
Company claims 90% efficacy at preventing disease, but experts call for data rather than press releases
News
Millions of microplastic particles released by some baby feeding bottles
2020-10-28T14:30:00
Hot water is key variable responsible for release of large numbers of plastic particles
News
First Covid-19 challenge study working with live virus planned for the UK
2020-10-20T13:52:00
Pending ethics panel approval, healthy volunteers would be infected with Sars-CoV-2 to help understand disease and test vaccines
Business
Protein-based Covid-19 vaccines could overshadow rivals
2020-09-17T13:27:00
Although slower to develop, protein-based vaccines are well understood with a strong record of safety and effectiveness
News
Rush to approve Covid vaccine prompted by politics may end in disaster
2020-09-16T08:30:00
Push by governments to pass a vaccine without appropriate evidence could damage fight against virus
Business
Russian Covid-19 vaccine data raises questions
2020-09-11T09:17:00
Suspected data manipulation or fabrication casts shadows over safety trial report for hastily-approved Sputnik V
Business
Russian vaccine launch shocks scientists
2020-08-14T14:36:00
Sputnik V to be approved without large human trial data
Business
Encouraging signs from initial Covid-19 vaccine trials
2020-08-11T08:28:00
Human trials deliver positive immune responses, while primate challenge studies suggest protection is possible
News
Horizon Europe budget cut prompts backlash from ERC’s scientific council
2020-07-20T13:45:00
Proposed reduction attacked as ‘retrograde step’
News
Hand-powered centrifuge setup can diagnose Covid-19 for just a dollar a test
2020-07-16T08:30:00
$5 centrifuge based on children’s toy part of raft of cheap technologies that can detect the virus in saliva in remote locations
News
Explainer: how is the vaccine pipeline for Covid-19 looking?
2020-06-30T08:46:00
The race to develop a vaccine is almost six months old. Who’s in the lead?
Business
Oil price crash ripples through chemicals production
2020-05-26T13:28:00
Fuel production slowdown will favour more flexible refiners as demand for petrochemicals is stable or increasing
News
Science steps up a gear as struggle to both understand and fight coronavirus intensifies
2020-04-16T13:30:00
Research that might have taken years is being turned around in months as journals fast-track Covid-19 manuscripts
Research
Structural studies offer glimpse of how coronavirus initiates human cell invasion
2020-04-03T09:46:00
Researchers studying virus receptor-binding domains suggest virus could have passed directly from bats to humans
Research
Potent coronavirus drug candidate designed using 3D structure of key viral enzyme
2020-03-27T10:45:00
Inhibitor of Sars-CoV-2 protease shows promise in early animal tests
Business
RNA vaccines are coronavirus frontrunners
2020-03-11T14:27:00
Several groups have potential Sars-CoV-2 vaccines ready or close to testing, thanks to rapid development pathways

More by Anthony King